ALPINE ASSOCIATES MANAGEMENT INC.
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 1396835
PALM BEACH, FL
Position in FOLD
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$23,080,907
+$9,564,299 QoQ
Shares Held
1,596,190
+68.2% QoQ
Ownership
0.508%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALPINE ASSOCIATES MANAGEMENT INC. holds $162,950,667 across 6 Biotechnology names. FOLD ranks #4 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
378,000 | $43,401,960 | |
| 2 | APLS |
Apellis Pharmaceuticals, Inc.
|
864,000 | $34,758,720 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
865,500 | $34,377,660 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
1,596,190 | $23,080,907 | |
| 5 | DAWN |
Day One Biopharmaceuticals, Inc.
|
925,000 | $19,832,000 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
142,250 | $7,499,420 |
All Filings in FOLD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,080,907 | 1,596,190 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $13,516,608 | 949,200 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||